Nalaganje...
A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?
There is no question that incretin-based glucose-lowering medications have proven to be effective glucose-lowering agents. Glucagon-like peptide 1 (GLP-1) receptor agonists demonstrate an efficacy comparable to insulin treatment and appear to do so with significant effects to promote weight loss wit...
Shranjeno v:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Diabetes Association
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3687282/ https://ncbi.nlm.nih.gov/pubmed/23645885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-2713 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|